Roche And Shandong Gallo Virology Institute To Establish Gene Diagnostics Center
This article was originally published in PharmAsia News
Roche Diagnostics APAC and Shandong Academy of Medical Sciences' Gallo Virology Institute recently established China's first personalized gene diagnostics center. The facility will provide personalized medicine and technologies to fight HIV/AIDS and other viral infectious diseases to meet medium- and long-term demands of the changing healthcare market in China. Both parties also signed a letter of intent to jointly conduct research in the field of diagnostics. Personalized medical care is a core strategy for Roche globally. With such solutions, physicians can conduct molecular testing and offer patients the most efficient and appropriate treatment programs. (Click here for more - Chinese Language)
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."